1. Home
  2. SCHL vs ABVX Comparison

SCHL vs ABVX Comparison

Compare SCHL & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCHL
  • ABVX
  • Stock Information
  • Founded
  • SCHL 1920
  • ABVX 2013
  • Country
  • SCHL United States
  • ABVX France
  • Employees
  • SCHL N/A
  • ABVX N/A
  • Industry
  • SCHL Books
  • ABVX
  • Sector
  • SCHL Consumer Discretionary
  • ABVX
  • Exchange
  • SCHL Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • SCHL 478.8M
  • ABVX 451.5M
  • IPO Year
  • SCHL 1987
  • ABVX N/A
  • Fundamental
  • Price
  • SCHL $17.02
  • ABVX $6.35
  • Analyst Decision
  • SCHL
  • ABVX Buy
  • Analyst Count
  • SCHL 0
  • ABVX 4
  • Target Price
  • SCHL N/A
  • ABVX $31.50
  • AVG Volume (30 Days)
  • SCHL 248.7K
  • ABVX 199.6K
  • Earning Date
  • SCHL 07-17-2025
  • ABVX 03-24-2025
  • Dividend Yield
  • SCHL 4.63%
  • ABVX N/A
  • EPS Growth
  • SCHL N/A
  • ABVX N/A
  • EPS
  • SCHL 0.65
  • ABVX N/A
  • Revenue
  • SCHL $1,592,100,000.00
  • ABVX $11,172,999.00
  • Revenue This Year
  • SCHL $3.42
  • ABVX $284.20
  • Revenue Next Year
  • SCHL $5.47
  • ABVX N/A
  • P/E Ratio
  • SCHL $26.49
  • ABVX N/A
  • Revenue Growth
  • SCHL N/A
  • ABVX 135.94
  • 52 Week Low
  • SCHL $15.77
  • ABVX $4.77
  • 52 Week High
  • SCHL $38.77
  • ABVX $14.71
  • Technical
  • Relative Strength Index (RSI)
  • SCHL 41.60
  • ABVX 53.40
  • Support Level
  • SCHL $16.81
  • ABVX $5.59
  • Resistance Level
  • SCHL $17.85
  • ABVX $6.09
  • Average True Range (ATR)
  • SCHL 0.67
  • ABVX 0.32
  • MACD
  • SCHL -0.10
  • ABVX 0.02
  • Stochastic Oscillator
  • SCHL 10.08
  • ABVX 86.36

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.

Share on Social Networks: